[Federal Register Volume 64, Number 231 (Thursday, December 2, 1999)] [Rules and Regulations] [Pages 67483-67486] From the Federal Register Online via the Government Publishing Office [www.gpo.gov] [FR Doc No: 99-31228] ======================================================================= ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration 21 CFR Part 178 [Docket No. 95F-0150] Indirect Food Additives: Adjuvants, Production Aids, and Sanitizers AGENCY: Food and Drug Administration, HHS. ACTION: Final rule. ----------------------------------------------------------------------- SUMMARY: The Food and Drug Administration (FDA) is amending the food additive regulations to provide for the safe use of 7-oxa-3,20- diazadispiro-[5.1.11.2]-heneicosan-21-one,2,2,4,4-tetramethyl- ,hydrochloride, reaction products with epichlorohydrin, hydrolyzed, polymerized (CAS Reg. No. 202483-55-4) as an antioxidant and/or stabilizer for polyolefins intended for contact with food. This action is in response to a petition filed by Hoechst Aktiengesellschaft. DATES: The regulation is effective December 2, 1999. Submit written objections and requests for a hearing by January 3, 2000. ADDRESSES: Submit written objections to the Dockets Management Branch (HFA-305), Food and Drug Administration, 5630 Fishers Lane, rm. 1061, Rockville, MD 20852. FOR FURTHER INFORMATION CONTACT: Vivian M. Gilliam, Center for Food Safety and Applied Nutrition (HFS-215), Food and Drug Administration, 200 C St. SW., Washington, DC 20204, 202-418-3094. SUPPLEMENTARY INFORMATION: I. Background In a notice published in the Federal Register of July 12, 1995 (60 FR 35914), FDA announced that a food additive petition (FAP 5B4461) had been filed by Hoechst Aktiengesellschaft, c/o 1001 G St. NW., suite 500 West, Washington, DC 20001. The petition proposed that the food additive regulations in Sec. 178.2010 Antioxidants and/or stabilizers for polymers (21 CFR 178.2010) be amended to provide for the safe use of polymeric 2,2,4,4-tetramethyl-7-oxa-3,20-diaza-20-(2,3-epoxypropyl)- dispiro-[5.1.11.2]-heneicosane-21-one (CAS Reg. No. 78301-43-6) as an antioxidant and/or stabilizer for polyolefins intended for contact with food. Subsequent to the filing of the petition, Hoechst Aktiengesellschaft sold its speciality business, including food additive petition 5B4461, to [[Page 67484]] Clariant AG, Switzerland. The petitioner also obtained a new Chemical Abstracts Service (CAS) Registry number for the additive under the following name: 7-oxa-3,20-diazadispiro-[5.1.11.2]-heneicosan-21- one,2,2,4,4-tetramethyl-,hydrochloride, reaction products with epichlorohydrin, hydrolyzed, polymerized (CAS Reg. No. 202483-55-4). In FDA's evaluation of the safety of 7-oxa-3,20-diazadispiro- [5.1.11.2]-heneicosan-21-one,2,2,4,4-tetramethyl-,hydrochloride, reaction products with epichlorohydrin, hydrolyzed, polymerized the agency reviewed the safety of the additive itself and the chemical impurities that may be present in the additive resulting from its manufacturing process. Although the additive itself has not been shown to cause cancer, it has been found to contain minute amounts of epichlorohydrin, a carcinogenic impurity resulting from the manufacture of the additive. Residual amounts of impurities are commonly found as constituents of chemical products, including food additives. II. Determination of Safety Under the general safety standard of the Federal Food, Drug, and Cosmetic Act (the act) (21 U.S.C. 348(c)(3)(A)), a food additive cannot be approved for a particular use unless a fair evaluation of the data available to FDA establishes that the additive is safe for that use. FDA's food additive regulations (21 CFR 170.3(i)) define safe as ``a reasonable certainty in the minds of competent scientists that the substance is not harmful under the intended conditions of use.'' The food additives anticancer, or Delaney, clause of the act (21 U.S.C. 348(c)(3)(A)) provides that no food additive shall be deemed safe if it is found to induce cancer when ingested by man or animal. Importantly, however, the Delaney clause applies to the additive itself and not to impurities in the additive. That is, where an additive itself has not been shown to cause cancer, but contains a carcinogenic impurity, the additive is properly evaluated under the general safety standard using risk assessment procedures to determine whether there is a reasonable certainty that no harm will result from the intended use of the additive. Scott v. FDA, 728 F.2d 322 (6th Cir. 1984). III. Safety of the Petitioned Use of the Additive FDA estimates that the petitioned use of the additive, 7-oxa-3,20- diazadispiro-[5.1.11.2]-heneicosan-21-one,2,2,4,4-tetramethyl- ,hydrochloride, reaction products with epichlorohydrin, hydrolyzed, polymerized, will result in exposure to no greater than 224 parts per billion (ppb) of the additive in the daily diet (3 kilogram (kg)) or an estimated daily intake of 0.67 milligram per person per day (mg/p/d) (Ref.1). FDA does not ordinarily consider chronic toxicological studies to be necessary to determine the safety of an additive whose use will result in such low exposure levels (Ref. 2), and the agency has not required such testing here. However, the agency has reviewed the available toxicological data on the additive and concludes that the estimated small dietary exposure resulting from the petitioned use of this additive is safe. FDA has evaluated the safety of this additive under the general safety standard, considering all available data and using risk assessment procedures to estimate the upper-bound limit of lifetime human risk presented by epichlorohydrin, the carcinogenic chemical that may be present as an impurity in the additive. The risk evaluation of epichlorohydrin has two aspects: (1) Assessment of exposure to the impurity from the petitioned use of the additive, and (2) extrapolation of the risk observed in the animal bioassays to the conditions of exposure to humans. A. Epichlorohydrin FDA has estimated the exposure to epichlorohydrin from the petitioned use of the additive as an antioxidant and/or stabilizer for polyolefins to be no more than 0.011 ppb in the daily diet (3 kg) or 33 nanograms (ng)/p/d (Ref.1). The agency used data from a carcinogenesis bioassay on epichlorohydrin conducted by Konishi et al. (Ref. 4), to estimate the upper-bound limit of lifetime human risk from exposure to this chemical resulting from the petitioned use of the additive. The authors reported that the test material caused significantly increased incidence of stomach papillomas and carcinomas in male rats. Based on the agency's estimate that exposure to epichlorohydrin will not exceed 33 ng/p/d, FDA estimates that the upper-bound limit of lifetime human risk from the petitioned use of the subject additive is 1.5 x 10-9 or 1.5 in a billion (Ref. 3). Because of the numerous conservative assumptions used in calculating the exposure estimate, the actual lifetime-averaged individual exposure to epichlorohydrin is likely to be substantially less than the estimated exposure, and therefore, the probable lifetime human risk would be less than the upper-bound limit of lifetime human risk. Thus, the agency concludes that there is reasonable certainty that no harm from exposure to epichlorohydrin would result from the petitioned use of the additive. B. Need for Specifications The agency has also considered whether specifications are necessary to control the amount of epichlorohydrin as an impurity in the additive. The agency finds that specifications are not necessary for the following reasons: (1) Because of the low level at which epichlorohydrin may be expected to remain as an impurity following production of the additive, the agency would not expect this impurity to become a component of food at other than extremely low levels; and (2) the upper-bound limit of lifetime human risk from exposure to epichlorohydrin is very low, 1.5 in a billion. IV. Conclusion FDA has evaluated data in the petition and other relevant material. Based on this information, the agency concludes that the proposed use of the additive as an antioxidant and/or stabilizer for polyolefins intended for contact with food is safe, and that the additive will achieve its intended technical effect. Therefore, the agency concludes that the regulations in Sec. 178.2010 should be amended as set forth below. In accordance with Sec. 171.1(h) (21 CFR 171.1(h)), the petition and the documents that FDA considered and relied upon in reaching its decision to approve the petition are available for inspection at the Center for Food Safety and Applied Nutrition by appointment with the information contact person listed above. As provided in Sec. 171.1(h), the agency will delete from the documents any materials that are not available for public disclosure before making the documents available for inspection. V. Paperwork Reduction Act of 1995 This final rule contains no collection of information. Therefore clearance by the Office of Management and Budget under the Paperwork Reduction Act of 1995 is not required. VI. Environmental Impact The agency has carefully considered the potential environmental effects of this action. FDA has concluded that the action will not have a significant impact on the human environment, and that an environmental impact statement is not required. The agency's finding of no significant impact and the evidence supporting that finding, contained in an environmental assessment, may be seen [[Page 67485]] in the Dockets Management Branch (address above) between 9 a.m. and 4 p.m., Monday through Friday. VII. Objections Any person who will be adversely affected by this regulation may at any time on or before January 3, 2000, file with the Dockets Management Branch (address above) written objections thereto. Each objection shall be separately numbered, and each numbered objection shall specify with particularity the provisions of the regulation to which objection is made and the grounds for the objection. Each numbered objection on which a hearing is requested shall specifically so state. Failure to request a hearing for any particular objection shall constitute a waiver of the right to a hearing on that objection. Each numbered objection for which a hearing is requested shall include a detailed description and analysis of the specific factual information intended to be presented in support of the objection in the event that a hearing is held. Failure to include such a description and analysis for any particular objection shall constitute a waiver of the right to a hearing on the objection. Three copies of all documents shall be submitted and shall be identified with the docket number found in brackets in the heading of this document. Any objections received in response to the regulation may be seen in the Dockets Management Branch between 9 a.m. and 4 p.m., Monday through Friday. VIII. References The following references have been placed on display in the Dockets Management Branch (address above) and may be seen by interested persons between 9 a.m. and 4 p.m., Monday through Friday. 1. Memorandum from A. B. Bailey, Chemistry and Environmental Review Team, to D. Harrison, Division of Petition Control, dated August 6, 1998. 2. Kokoski, C. J., ``Regulatory Food Additive Toxicology,'' in Chemical Safety Regulation and Compliance, edited by F. Homburger, and J. K. Marquis, New York, NY, pp. 24-33, 1985. 3. Memo from Division of Petition Control (HFS-215) to Sara H. Henry, Quantitative Risk Assessment Committee (HFS-308), ``Verification of upper bound risk calculation for epichlorohydrin (ECH) for petition No. FAP 5B4461,'' dated February 10, 1998. 4. Konishi, Y. et al., ``Forestomach Tumors Induced by Orally Administered Epichlorohydin in Male Wistar Rats,'' Gann, 71:922-923, 1980. List of Subjects in 21 CFR Part 178 Food additives, Food packaging. Therefore, under the Federal Food, Drug, and Cosmetic Act and under authority delegated to the Commissioner of Food and Drugs, 21 CFR part 178 is amended as follows: PART 178--INDIRECT FOOD ADDITIVES: ADJUVANTS, PRODUCTION AIDS, AND SANITIZERS 1. The authority citation for 21 CFR part 178 continues to read as follows: Authority: 21 U.S.C. 321, 342, 348, 379e. 2. Section 178.2010 is amended in the table in paragraph (b) by alphabetically adding a new entry under the headings ``Substances'' and ``Limitations'' to read as follows: Sec. 178.2010 Antioxidants and/or stabilizers for polymers. * * * * * (b) * * * ---------------------------------------------------------------------------------------------------------------- Substances Limitations ---------------------------------------------------------------------------------------------------------------- * * * * * * * 7-Oxa-3,20-diazadispiro-[5.1.11.2]-heneicosan-21- For use only: one,2,2,4,4-tetramethyl-,hydrochloride, reaction 1. At levels not to exceed 0.5 percent by weight of products with epichlorohydrin, hydrolyzed, polymerized olefin polymers complying with Sec. 177.1520 of this (CAS Reg. No. 202483-55-4). chapter, items 1.1, 3.1, and 3.2, where the copolymers complying with items 3.1 and 3.2 contain not less than 85 weight percent of polymer units derived from propylene; in contact with all types of food described in Table 1 of Sec. 176.170 of this chapter, provided that the finished food-contact article will have a capacity of at least 18.9 liters (5 gallons) when in contact with food of types III, IV-A, V, VII-A, and IX, described in Table 1 of Sec. 176.170 of this chapter. 2. At levels not to exceed 0.5 percent by weight of olefin polymers complying with Sec. 177.1520 of this chapter, items 2.1, 2.2, 3.1, and 3.2, having a density of not less than 0.94 gram/milliliter, where the copolymers complying with items 3.1 and 3.2 contain not less than 85 weight percent of polymer units derived from ethylene; in contact with food only under conditions of use C, D, E, F, and G, described in Table 2 of Sec. 176.170 of this chapter, provided that the finished food-contact article will have a capacity of at least 18.9 liters (5 gallons) when in contact with food of types III, IV-A, V, VII-A, and IX, described in Table 1 of Sec. 176.170 of this chapter. 3. At levels not to exceed 0.3 percent by weight of olefin polymers complying with Sec. 177.1520 of this chapter, items 2.1, 2.2, 3.1, 3.2, 3.3, 3.4, 3.5, 3.6, and 4.0, having a density of less than 0.94 gram/ milliliter, in contact with food only under conditions of use D, E, F, and G, described in Table 2 of Sec. 176.170 of this chapter, provided that the finished food-contact article will have a capacity of at least 18.9 liters (5 gallons) except that, films and molded articles containing not more than 0.2 percent by weight of the stabilizer may contact aqueous food of types I, II, IV-B, VI, and VIII, described in Table 1 of Sec. 176.170 of this chapter with no restrictions on the amount of food contacted. * * * * * * * ---------------------------------------------------------------------------------------------------------------- [[Page 67486]] Dated: November 23, 1999. Margaret M. Dotzel, Acting Associate Commissioner for Policy. [FR Doc. 99-31228 Filed 12-1-99; 8:45 am] BILLING CODE 4160-01-F
Document
Indirect Food Additives: Adjuvants, Production Aids, and Sanitizers
The Food and Drug Administration (FDA) is amending the food additive regulations to provide for the safe use of 7-oxa-3,20- diazadispiro-[5.1.11.2]-heneicosan-21-one,2,2,4,4-tet...
Legal Citation
Federal Register Citation
Use this for formal legal and research references to the published document.
64 FR 67483
Web Citation
Suggested Web Citation
Use this when citing the archival web version of the document.
“Indirect Food Additives: Adjuvants, Production Aids, and Sanitizers,” thefederalregister.org (December 2, 1999), https://thefederalregister.org/documents/99-31228/indirect-food-additives-adjuvants-production-aids-and-sanitizers.